Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-22

Clinical Trial Update: Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders [Phase 4]

View source ↗

Summary

Phase 4 trial of sertraline for social phobia with co-occurring anxiety and mood disorders has been terminated. The study examined sertraline across comorbid co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sertraline (Zoloft) (Sertraline)

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Phobia, Social, Panic Disorder | Phase 4 | Status: TERMINATED